|
RGNX Regenxbio Inc 1590877 |
| Balance Sheet |
|
Current Assets
|
$236,157,000.00 |
|
Assets
|
$386,618,000.00 |
|
Current Liabilities
|
$82,621,000.00 |
|
Liabilities
|
$314,853,000.00 |
|
Equity
|
$71,765,000.00 |
|
Shares Out
|
54164000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-138,424,000.00 |
|
Investing Cash Flow
|
$136,513,000.00 |
| Market Analysis |
Market Cap
|
$599,053,840.00 |
|
Price
|
$11.06 |
|
BVPS
|
1.33 |
|
PB
|
8.32 |
|
EPS
|
0.43 |
|
PS
|
1.39 |
|
FCF
|
$-140,419,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:32 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-1.30 |
|
|
2026-05-14 |
-1.72 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.38 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.20 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RGNX documents filed with the SEC.
RGNX Filings
Clear
